Choices in vaccine trial design in epidemics of emerging infections.

Choices in vaccine trial design in epidemics of emerging infections.

In a Policy Forum, Marc Lipsitch and colleagues discuss trial design issues in infectious disease outbreaks.

Bibliographic Details
Main Authors:	Rebecca Kahn, Annette Rid, Peter G Smith, Nir Eyal, Marc Lipsitch
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-08-01
Series:	PLoS Medicine
Online Access:	https://doi.org/10.1371/journal.pmed.1002632

Similar Items

Using simulation to aid trial design: Ring-vaccination trials.
by: Matt David Thomas Hitchings, et al.
Published: (2017-03-01)

Design of vaccine efficacy trials for priority emerging and epidemic diseases
by: Watson, C, et al.
Published: (2019)

140:poster The ethics of global COVID-19 vaccine allocation
by: Joseph Millum, et al.
Published: (2022-04-01)

Alert Threshold Algorithms and Malaria Epidemic Detection
by: Hailay Desta Teklehaimanot, et al.
Published: (2004-07-01)

Bacterial Vaccines and Serotype Replacement: Lessons from Haemophilus influenzae and Prospects for Streptococcus pneumoniae
by: Marc Lipsitch
Published: (1999-06-01)

Vaccines for epidemic infections and the role of CEPI
by: Stanley A. Plotkin
Published: (2017-12-01)

Just health: meeting health needs fairly
by: Annette Rid
Published: (2008-08-01)

Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation
by: Virgil Schijns, et al.
Published: (2021-04-01)

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel
by: Gili Regev-Yochay, et al.
Published: (2021-08-01)

Evolution of virulence in emerging epidemics.
by: Thomas W Berngruber, et al.
Published: (2013-03-01)

Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a whole-cell vaccine.
by: Francisco Y Cai, et al.
Published: (2018-10-01)

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?
by: Marc Lipsitch, et al.
Published: (2016-07-01)

A note on epidemic models with infective immigrants and vaccination
by: Eunha Shim
Published: (2006-04-01)

An Epidemic Model with Infection Age and Vaccination Age Structure
by: Glenn Webb, et al.
Published: (2024-01-01)

Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics
by: Kevin C Ma, et al.
Published: (2021-05-01)

The importance of choice disability and structural intervention in the HIV epidemic in Sub-Saharan Africa.
by: Rebecca de Boer, et al.
Published: (2017-01-01)

Design of vaccine efficacy trials during public health emergencies
by: Dean, N, et al.
Published: (2019)

Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
by: Joseph A. Lewnard, et al.
Published: (2023-06-01)

Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines
by: Huub F. J. Savelkoul, et al.
Published: (2015-03-01)

Note of clarification
by: Annette Rid, et al.
Published: (2013-05-01)

Controversies in the determination of death: perspectives from Switzerland
by: Settimio Monteverde, et al.
Published: (2012-08-01)

Observational research in epidemic settings: a roadmap to reform
by: Marc Lipsitch, et al.
Published: (2025-02-01)

Emerging Viral and Bacterial Infections: Within an Era of Opioid Epidemic
by: Jessica F. Jones, et al.
Published: (2020-09-01)

Weather-based prediction of <it>Plasmodium falciparum </it>malaria in epidemic-prone regions of Ethiopia I. Patterns of lagged weather effects reflect biological mechanisms
by: Teklehaimanot Hailay D, et al.
Published: (2004-11-01)

Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study
by: Stefan Flasche, et al.
Published: (2020-06-01)

Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a bivalent A/H3N2 vaccine component
by: Colin J. Worby, et al.
Published: (2017-06-01)

Zika: The Emerging Epidemic
by: Maciej F. Boni
Published: (2017-10-01)

The essential role of Data and Safety Monitoring Boards (DSMBs) in ensuring the ethics of global vaccine trials to address Coronavirus disease 2019 (COVID-19O)
by: Eckstein, L, et al.
Published: (2021)

Emerging norms for the control of emerging epidemics
by: Christopher W McDougall, et al.
Published: (2008-08-01)

Mathematical analysis and optimal control of an epidemic model with vaccination and different infectivity
by: Lili Liu, et al.
Published: (2023-11-01)

Designing a multi-epitope vaccine to control porcine epidemic diarrhea virus infection using immunoinformatics approaches
by: Wei Hou, et al.
Published: (2023-09-01)

School Choice Policies in the Political Spectacle
by: Linda Miller-Kahn, et al.
Published: (2001-11-01)

Measuring force of infection and vaccine effects on transmission stages in clinical trials of experimental malaria vaccines
by: Felger Ingrid, et al.
Published: (2012-10-01)

Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies
by: Bastian Steuwer, et al.
Published: (2021-04-01)

Weather-based prediction of <it>Plasmodium falciparum </it>malaria in epidemic-prone regions of Ethiopia II. Weather-based prediction systems perform comparably to early detection systems in identifying times for interventions
by: Teklehaimanot Hailay D, et al.
Published: (2004-11-01)

Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method.
by: Edward Goldstein, et al.
Published: (2011-07-01)

Vaccination in a model of an epidemic
by: M. S. Abual-Rub
Published: (2000-01-01)

Controlling epidemics with transmissible vaccines.
by: Scott L Nuismer, et al.
Published: (2018-01-01)

Bronchiectasis: an emerging global epidemic
by: Sanjay H. Chotirmall, et al.
Published: (2018-05-01)

Zika virus: An emerging epidemic
by: Anna Ratanacharoensiri, et al.
Published: (2017-01-01)